Cancer Genomics - Proteomics: 16 (2)

March-April 2019; Volume 16,Issue 2

Open Access
MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer
ULRICH H. WEIDLE, FABIAN BIRZELE and ADAM NOPORA

Cancer Genomics & Proteomics March 2019, 16 (2) 99-119; DOI: https://doi.org/10.21873/cgp.20116
Open Access
Correlation of TERT and Stem Cell Markers in the Context of Human Breast Cancer
UMAR WAZIR, MONA M.A.W. ORAKZAI, TRACEY AMANDA MARTIN, WEN G. JIANG and KEFAH MOKBEL

Cancer Genomics & Proteomics March 2019, 16 (2) 121-127; DOI: https://doi.org/10.21873/cgp.20117
Open Access
Serum Proteomic Signatures of Male Breast Cancer
ELENI ZOGRAFOS, ATHANASIOS K. ANAGNOSTOPOULOS, AGGELIKI PAPADOPOULOU, EVANGELIA LEGAKI, FLORA ZAGOURI, EVANGELOS MARINOS, GEORGE T. TSANGARIS and MARIA GAZOULI

Cancer Genomics & Proteomics March 2019, 16 (2) 129-137; DOI: https://doi.org/10.21873/cgp.20118
Open Access
MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy
PARWEZ AHMAD, JIRI SANA, MAREK SLAVIK, DOMINIK GURIN, LENKA RADOVA, NATALIA ANNA GABLO, TOMAS KAZDA, PAVEL SMILEK, ZUZANA HORAKOVA, BRETISLAV GAL, MARKETA HERMANOVA, PAVEL SLAMPA and ONDREJ SLABY

Cancer Genomics & Proteomics March 2019, 16 (2) 139-146; DOI: https://doi.org/10.21873/cgp.20119

Main menu